#8 Diagnostic Biochips CEO Greg Alden on NeuroTech Innovation, Parkinson’s, Management, and more

Interview with Greg Alden. He is the CEO of Diagnostic Biochips – a company providing high fidelity research tools to neuroscientists for electrophysiology and more.  He spent the early years of his career optimizing data communications to solve big problems in the domains of broadband and mobile communications.  He now brings this set of useful expertise to the neurotech world.  We have a conversation talking about everything from the future of neurotechnology innovation, Greg’s journey into the field (in part sparked by his diagnosis with a neurological condition), management principles for a technical organization, and more! Recorded January 16, 2024. Hosts: Robert Murcko and Yuqing Wang. Key Moments 0:00 Intro 1:54 Parkinson’s Diagnosis 3:06 Applying Tech to Neuro Problems 4:08 Brain as a Distributed Computing Networking Function 5:03 Interest in Neuroscience 7:14 Involvement with Diagnostic Biochips 9:46 Commercialization of Diagnostic Biochips’ Products 11:30 Transitioning from Telecom to Neurotech 14:03 Market Landscape and Diagnostic Biochips’ Place In It 17:21 From Idea Stage through Go-to-Market 21:20 Advice for Academics Looking to Translate Their Technology 23:59 Technical vs. Business Priorities 26:29 Diagnostic Biochips’ Products and Offerings 29:28 Cloud-Based Analysis Platform 35:24 Diagnostic Biochips Contributions to the Field of Neuroscience 40:03 Advice for Getting Involved with Neurotech 42:23 The Future of Neurotechnology 46:42 Conclusion and Contact Information Links Free Neurotech Newsletter: https://neurotechnologynews.beehiiv.com/subscribe   Diagnostic Biochips: https://diagnosticbiochips.com/   Greg’s LinkedIn: https://www.linkedin.com/in/gregjalden/

There are no comments yet.

Please log in to write the first comment.